Literature DB >> 4570291

Doxycycline treatment of chronic trachoma.

I Hoshiwara, H B Ostler, L Hanna, F Cignetti, V R Coleman, E Jawetz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4570291

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  14 in total

1.  Editorial: Chlamydia, trachoma, genital infection, and psittacosis.

Authors: 
Journal:  Br J Ophthalmol       Date:  1975-03       Impact factor: 4.638

2.  Trachoma.

Authors:  D Mabey; N Fraser-Hurt
Journal:  BMJ       Date:  2001-07-28

3.  Elimination of trachoma: are we in danger of being blinded by the randomised controlled trial?

Authors:  H R Wright; J E Keeffe; H R Taylor
Journal:  Br J Ophthalmol       Date:  2006-11       Impact factor: 4.638

Review 4.  Infectious diseases: annual review of significant publications.

Authors:  H A Reimann
Journal:  Postgrad Med J       Date:  1974-08       Impact factor: 2.401

5.  Severe endemic trachoma in Tunisia. I. Effect of topical chemotherapy on conjunctivitis and ocular bacteria.

Authors:  D W Vastine; C R Dawson; T Daghfous; M Messadi; I Hoshiwara; C Yoneda; R Nataf
Journal:  Br J Ophthalmol       Date:  1974-10       Impact factor: 4.638

Review 6.  Spectrum of human chlamydial infections.

Authors: 
Journal:  West J Med       Date:  1981-09

7.  Chlorhexidine as an effective agent against Chlamydia trachomatis in vitro and in vivo.

Authors:  I T Nisbet; D M Graham; P E Spicer; G J Tibbs
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

8.  Epidemiology and therapy of Chlamydia trachomatis infections.

Authors:  W R Bowie
Journal:  Drugs       Date:  1984-05       Impact factor: 9.546

Review 9.  Trachoma.

Authors:  Anthony Solomon; David Mabey
Journal:  BMJ Clin Evid       Date:  2007-11-07

10.  Severe endemic trachoma in Tunisia.

Authors:  C R Dawson; T Daghfous; M Messadi; I Hoshiwara; J Schachter
Journal:  Br J Ophthalmol       Date:  1976-04       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.